secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001213900-25-122777
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud

Neuphoria Therapeutics Announces Annual Meeting Voting Results; Elects Two Class I Directors
--------------------------------------------------------------------------------

- Shareholders elected Peter Miles Davies (759,850 votes for) and David Wilson (758,571) as Class I directors.
- Ratification of Wolf & Company P.C. as auditor passed with 807,022 votes in favor.
- Non-binding advisory vote on executive compensation approved with 726,184 votes for.
- On frequency of advisory votes, three years received the most votes (585,857), though non-binding.
- Approximately 39.76% of outstanding shares (937,447) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025122777/0001213900-25-122777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025122777/ea0270035-8k_neuphoria.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-122777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer